T. Rowe Price Investment Management Portfolio holdings
T. Rowe Price Investment Management, Inc. (TRPIM), a division of T. Rowe Price Group established in August 2022 and headquartered in Baltimore, Maryland, is an active investment manager overseeing hundreds of billions in assets, focusing on equity and fixed-income strategies for institutional clients and sub-advisory mandates. Spun off from the parent company founded in 1937 by Thomas Rowe Price, Jr., TRPIM operates as a distinct entity with around 900 employees, emphasizing a research-driven, long-term approach rooted in fundamental analysis and disciplined risk management. Managing portfolios like large-cap growth and international equity funds, it complements T. Rowe Price’s broader offerings while targeting sophisticated investors such as pension funds and endowments with tailored, high-conviction solutions. Under the leadership of president Rob Sharps, TRPIM upholds the firm’s legacy of integrity and client focus, adapting its founder’s value-oriented philosophy to modern institutional needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$4.62B |
| 2 |
Ingersoll Rand
IR
|
+$2.99B |
| 3 |
Fortive
FTV
|
+$2.58B |
| 4 |
Apple
AAPL
|
+$2.46B |
| 5 |
Yum! Brands
YUM
|
+$2.1B |
Top Sells
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.71% |
| 2 | Healthcare | 21.85% |
| 3 | Financials | 13.14% |
| 4 | Consumer Discretionary | 12.07% |
| 5 | Industrials | 11.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Fate Therapeutics
FATE
$316M
| $9.1M | 0.01% |
+406,144
| New | +$11.7M |
|
502
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$7.33B
| $8.96M | 0.01% |
+102,000
| New | +$9.5M |
|
503
Monolithic Power Systems
MPWR
$69.5B
| $8.87M | 0.01% |
+24,404
| New | +$10.9M |
|
504
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.9B
| $8.85M | 0.01% |
+124,000
| New | +$9.37M |
|
505
Artesian Resources
ARTNA
$364M
| $8.71M | 0.01% |
+181,107
| New | +$9.63M |
|
506
Ardagh Metal Packaging
AMBP
$3.13B
| $8.62M | 0.01% |
+1,781,243
| New | +$10.9M |
|
507
Rapid Micro Biosystems
RPID
$84.8M
| $8.55M | 0.01% |
+2,646,612
| New | +$10.3M |
|
508
Repligen
RGEN
$9.37B
| $8.11M | 0.01% |
+43,358
| New | +$9.14M |
|
509
HubSpot
HUBS
$10.7B
| $7.56M | 0.01% |
+27,995
| New | +$8.89M |
|
510
Red Robin
RRGB
$192M
| $7.56M | 0.01% |
+1,122,856
| New | +$9.16M |
|
511
Genius Sports
GENI
$2.17B
| $7M | 0.01% |
+1,906,493
| New | +$6.86M |
|
512
Oxford Industries
OXM
$543M
| $6.82M | 0.01% |
+75,998
| New | +$7.35M |
|
|
USX
513
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
| $6.77M | 0.01% |
+2,753,550
| New | +$7.8M |
|
514
Immuneering
IMRX
$334M
| $6.56M | 0.01% |
+458,233
| New | +$3.64M |
|
|
NXDT
515
NexPoint Diversified Real Estate Trust
NXDT
$258M
| $6.47M | 0.01% |
+515,358
| New | +$8.01M |
|
516
Hayward Holdings
HAYW
$3.23B
| $6.03M | ﹤0.01% |
+679,979
| New | +$8M |
|
517
ThredUp
TDUP
$411M
| $5.99M | ﹤0.01% |
+3,254,503
| New | +$8.16M |
|
518
Repay Holdings
RPAY
$312M
| $5.83M | ﹤0.01% |
+826,385
| New | +$9.01M |
|
|
INFN
519
DELISTED
Infinera Corporation Common Stock
INFN
| $5.81M | ﹤0.01% |
+1,200,160
| New | +$6.58M |
|
520
CVRx
CVRX
$75.4M
| $5.74M | ﹤0.01% |
+615,159
| New | +$4.87M |
|
|
HZN
521
DELISTED
Horizon Global Corporation
HZN
| $5.61M | ﹤0.01% |
+4,561,534
| New | +$7.11M |
|
|
XM
522
DELISTED
Qualtrics International Inc. Class A Common Stock
XM
| $5M | ﹤0.01% |
+491,303
| New | +$6.1M |
|
523
C4 Therapeutics
CCCC
$481M
| $4.8M | ﹤0.01% |
+547,667
| New | +$5.69M |
|
524
Adaptive Biotechnologies
ADPT
$4B
| $4.78M | ﹤0.01% |
+671,802
| New | +$6.33M |
|
525
Tenaya Therapeutics
TNYA
$171M
| $4.54M | ﹤0.01% |
+1,564,745
| New | +$7.3M |
|
Similar funds
T. Rowe Price Investment Management's Q3 2022 Portfolio in Review
Q3 2022 is the first quarter with a 13F filing on record for T. Rowe Price Investment Management, which disclosed 541 positions worth $125B. Its ten largest holdings account for 18% of the portfolio.
Its largest position is Microsoft: 17,509,233 shares worth $4.08B.
By sector, the portfolio is most concentrated in Technology at 26% of assets, followed by Healthcare and Financials.
- T. Rowe Price Investment Management's largest Q3 2022 buy was Microsoft: 17,509,233 shares worth $4.08B.
- T. Rowe Price Investment Management's ten largest holdings make up 18% of its $125B portfolio in Q3 2022.
- T. Rowe Price Investment Management disclosed 541 positions in Q3 2022, its first 13F filing on record.
Based on T. Rowe Price Investment Management's 13F filing for Q3 2022, filed 14 Nov 2022.